A resolution to urge the United States Congress to pass the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act of 2023.

This House resolution urges Congress to pass the Kidney PATIENT Act of 2023, which aims to protect access to essential oral medications for dialysis patients. The proposed law would delay a scheduled change to Medicare payment rules that would have shifted coverage for certain kidney drugs from Part D to a bundled dialysis payment system starting in 2025. By postponing this shift until 2033 or until an approved intravenous alternative is available, the bill seeks to prevent potential disruptions in medication availability for people with end-stage renal disease. The measure directly affects the roughly 808,000 Americans living with end-stage renal disease and specifically highlights concerns for minority and low-income communities who rely on these treatments.